ClinicalTrials.Veeva

Menu

Screening of Hereditary Upper Gastrointestinal Cancer in China

P

Peking University

Status

Unknown

Conditions

Improve the Screening Criteria of Chinese Hereditary Upper Gastrointestinal Tumors

Treatments

Diagnostic Test: Gene detection

Study type

Observational

Funder types

Other

Identifiers

NCT03130621
CGOG1012

Details and patient eligibility

About

Through exploring the specific genetic mutations in the upper gastrointestinal tract tumors with a family history and specific clinical pathological types,we establish a complete family and follow-up system,in order to improve the screening criteria of Chinese hereditary upper gastrointestinal tumors and carry on primary prevention of disease.

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with gastric cancer, esophageal adenocarcinoma, or duodenal adenocarcinoma meet one of the following criteria:

  1. age≤30;
  2. age≤35,gastric cancer with special pathological types;
  3. age≤50,≥one first-degree relative of a malignant tumor;
  4. ≥ two first-degree/second-degree relatives of a malignant tumor,and ≥one first-degree relative;
  5. have ≥two types of malignancies,and age ≤50 at the first time of diagnosis;
  6. MSI or dMMR of tissue specimen;

Patients with esophageal squamous cell carcinomas meet one of the following criteria:

  1. ≥ two first-degree/second-degree relatives of a malignant tumor,and ≥one first-degree relative;
  2. have ≥two types of malignancies,and age ≤50 at the first time of diagnosis;
  3. MSI or dMMR of tissue specimen;

Exclusion criteria

  • Patients do not meet one of the inclusion criteria;

Trial design

500 participants in 2 patient groups

Adenocarcinoma of upper digestive tract
Description:
Early-onset carcinomas ; Family History of Malignancy; Special pathological type; MSI or dMMR; Multiple primary malignant tumors;
Treatment:
Diagnostic Test: Gene detection
Esophageal squamous cell carcinoma
Description:
Family History of Malignancy; Multiple primary malignant tumors; MSI or dMMR;
Treatment:
Diagnostic Test: Gene detection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems